Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
Zhi Shi1, Ning Wang2, Ying-Jie Zhang3
1Department of Cell Biology & Institute of Biomedicine, National Engineering Research Center of Genetic Medicine, MOE Key Laboratory of Tumor Molecular Biology, Guangdong Provincial Key Laboratory of Bioengineering Medicine, College of Life Science and Technology, Jinan University, Guangzhou, Guangdong, China.
Frontiers in Pharmacology
|August 25, 2022
Abstract
No abstract available in PubMed .


